UVA Today2d
New Drug Could Block COVID-19 Before It Starts, Study Finds
UVA School of Medicine emeritus professor Dr. Frederick G. Hayden helped design the trial and presented the results Wednesday ...
Best Life on MSN2d
New Drug Can Reduce COVID Risk By 67%, Research Shows—If You Take It at This Time
Medicines like Paxlovid exist to treat COVID in high-risk people by preventing the virus from multiplying if taken at the ...
Drug may prevent COVID-19 in exposed people within households, major trial finds
An international clinical trial has identified a medication that can help prevent symptomatic COVID-19 in people exposed ...
Pharmabiz5h
NIH-sponsored trial data shows tecovirimat is safe but ineffective as treatment for clade II mpox
Bethesda, Maryland Saturday, March 15, 2025, 10:00 Hrs [IST] ...
News-Medical.Net8d
Could CRISPR Help Prevent the Next Global Pandemic?
CRISPR technology offers innovative solutions for pandemic preparedness, enhancing diagnostics, antiviral therapies, and ...
NanoViricides Not Affected by Tariffs and Other Policies, Has Excellent Long Term Outlook, Stock-Price Decline Misguided, Explains the Company
NanoViricides, Inc. (the “Company”)(NYSE American:NNVC), a clinical-stage global leader developing revolutionary broad-spectrum antiviral drugs that the viruses cannot escape, declared today that its ...
Open Access Government2d
UK launches genomic surveillance program to combat hepatitis C and enhance treatment strategies
The UK Health Security Agency (UKHSA) has recently launched a genomic surveillance programme to monitor the HCV and its ...